Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions

Radiology

Volumn 261, Issue 3, 2011, Pages 752-761

  Gruber, Stephan ^a   Debski, Bogumil Krystian ^a   Pinker, Katja ^a   Chmelik, Marek ^a   Grabner, Guenther ^a   Helbich, Thomas ^a   Trattnig, Siegfried ^a   Bogner, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; BREAST CYST; BREAST FIBROADENOMA; BREAST LESION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ECHOMAMMOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FIBROCYSTIC BREAST DISEASE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; MAMMOGRAPHY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; CHOLINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 81555218169     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11102096     Document Type: Article

References (46)

1. Kuhl CK, Jost P, Morakkabati N, Zivanovic O, Schild HH, Gieseke J. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients:initial experience. Radiology 2006;239(3):666-676. (Pubitemid 43830601)
2. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced Turbo- FLASH subtraction technique. Radiology 1994;193(3):777-781.
3. Kuhl C. The current status of breast MR imaging. I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007;244(2):356-378. (Pubitemid 47080868)
4. Pinker K, Grabner G, Bogner W, et al. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions:initial results. Invest Radiol 2009;44(9):553-558.
5. Riedl CC, Ponhold L, Flöry D, et al. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 2007;13(20):6144-6152. (Pubitemid 350075074)
6. Warner E. The role of magnetic resonance imaging in screening women at high risk of breast cancer. Top Magn Reson Imaging 2008;19(3):163-169.
7. Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast:recommendations from the EUSOMA working group. Eur J Cancer 2010;46(8):1296-1316.
8. Morris EA, Liberman L. Breast MRI. New York, NY :Springer, 2005.
9. Crystal P, Sadaf A, Bukhanov K, McCready D, O'Malley F, Helbich TH. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy:can underestimation be predicted? Eur Radiol 2011;21(3):582-589.
10. Weinstein SP, Hanna LG, Gatsonis C, Schnall MD, Rosen MA, Lehman CD. Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging:findings from ACRIN 6667. Radiology 2010;255(3):731-737.
11. Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006;239(3):686-692. (Pubitemid 43830603)
12. Bartella L, Thakur SB, Morris EA, et al. Enhancing nonmass lesions in the breast:evaluation with proton(1H) MR spectroscopy. Radiology 2007;245(1):80-87. (Pubitemid 47417790)
13. Meisamy S, Bolan PJ, Baker EH, et al. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging:preliminary results of observer performance study at 4.0 T. Radiology 2005;236(2):465-475. (Pubitemid 41023427)
14. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions:characterization with proton MR spectroscopy. Radiology 1998;209(1):269-275. (Pubitemid 28464677)
15. Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA. Proton magnetic resonance spectroscopic imaging of human breast cancer:a preliminary study. J Magn Reson Imaging 2004;19(1):68-75. (Pubitemid 38055731)
16. Sardanelli F, Fausto A, Di Leo G, de Nijs R, Vorbuchner M, Podo F. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. AJR Am J Roentgenol 2009;192(6):1608-1617.
17. Yeung DK, Cheung HS, Tse GM. Human breast lesions:characterization with contrastenhanced in vivo proton MR spectroscopy-initial results. Radiology 2001;220(1):40-46. (Pubitemid 32577957)
18. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68(1):45-54. (Pubitemid 32928270)
19. Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 1999;19(3A):1737-1746. (Pubitemid 29392730)
20. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo(1)H MR spectroscopy. J Magn Reson Imaging 1999;10(2):159-164. (Pubitemid 29362430)
21. Kim JK, Park SH, Lee HM, et al. In vivo 1H-MRS evaluation of malignant and benign breast diseases. Breast 2003;12(3):179-182. (Pubitemid 36665515)
22. Tse GM, Cheung HS, Pang LM, et al. Characterization of lesions of the breast with proton MR spectroscopy:comparison of carcinomas, benign lesions, and phyllodes tumors. AJR Am J Roentgenol 2003;181(5):1267-1272. (Pubitemid 37296401)
23. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM. Detection of breast malignancy:diagnostic MR protocol for improved specificity. Radiology 2004;232(2):585-591. (Pubitemid 38971303)
24. Bolan PJ, Meisamy S, Baker EH, et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 2003;50(6):1134-1143. (Pubitemid 37494015)
25. Lenkinski RE, Wang X, Elian M, Goldberg SN. Interaction of gadolinium-based MR contrast agents with choline:implications for MR spectroscopy(MRS) of the breast. Magn Reson Med 2009;61(6):1286-1292.
26. Hu J, Vartanian SA, Xuan Y, Latif Z, Soulen RL. An improved 1H magnetic resonance spectroscopic imaging technique for the human breast:preliminary results. Magn Reson Imaging 2005;23(4):571-576. (Pubitemid 40779244)
27. Hu J, Feng W, Hua J, et al. A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3 T. Med Phys 2009;36(11): 4870-4877.
28. Sijens PE, Dorrius MD, Kappert P, Baron P, Pijnappel RM, Oudkerk M. Quantitative multivoxel proton chemical shift imaging of the breast. Magn Reson Imaging 2010;28(3):314-319.
29. Hu J, Yu Y, Kou Z, et al. A high spatial resolution 1H magnetic resonance spectroscopic imaging technique for breast cancer with a short echo time. Magn Reson Imaging 2008;26(3):360-366. (Pubitemid 351324892)
30. American College of Radiology. Breast imaging reporting and data system(BI-RADS). Reston, Va :American College of Radiology, 1998.
31. Helbich TH, Matzek W, Fuchsjäger MH. Stereotactic and ultrasound-guided breast biopsy. Eur Radiol 2004;14(3):383-393. (Pubitemid 38324912)
32. Baik HM, Su MY, Yu H, Mehta R, Nalcioglu O. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA 2006;19(2):96-104.
33. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002;94(16):1197-1203. (Pubitemid 34993869)
34. Haddadin IS, McIntosh A, Meisamy S, et al. Metabolite quantification and highfi eld MRS in breast cancer. NMR Biomed 2009;22(1):65-76.
35. Vaughan JT, Snyder CJ, DelaBarre LJ, et al. Whole-body imaging at 7T:preliminary results. Magn Reson Med 2009;61(1):244-248.
36. Yeung DK, Yang WT, Tse GM. Breast cancer:in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002;225(1):190-197.
37. Tozaki M, Fukuma E. 1H MR spectroscopy and diffusion-weighted imaging of the breast:are they useful tools for characterizing breast lesions before biopsy? AJR Am J Roentgenol 2009;193(3):840-849.
38. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001;84(8):1016-1022. (Pubitemid 32448495)
39. Jacobs MA, Barker PB, Argani P, Ouwerkerk R, Bhujwalla ZM, Bluemke DA. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging:a feasibility study. J Magn Reson Imaging 2005;21(1):23-28. (Pubitemid 40041416)
40. Bogner W, Gruber S, Pinker K, et al. Diffusion- weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 2009;253(2):341-351.
41. Baik HM, Su MY, Yu H, Mehta R, Nalcioglu O. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA 2006;19(2):96-104.
42. Bolan PJ, Henry PG, Baker EH, Meisamy S, Garwood M. Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla. Magn Reson Med 2004;52(6):1239-1245. (Pubitemid 39612811)
43. Hess AT, Dylan Tisdall M, Andronesi OC, Meintjes EM, van der Kouwe AJ. Real-time motion and B(0) corrected single voxel spectroscopy using volumetric navigators. Magn Reson Med 2011;66(2):314-323.
44. Ackerstaff E, Glunde K, Bhujwalla ZM. Choline phospholipid metabolism:a target in cancer cells? J Cell Biochem 2003;90(3):525-533. (Pubitemid 37243700)
45. Chen JH, Mehta RS, Baek HM, et al. Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS. NMR Biomed 2011;24(3):316-324.
46. Klomp DW, van de Bank BL, Raaijmakers A, et al.(31) P MRSI and(1) H MRS at 7 T: initial results in human breast cancer. NMR Biomed. doi:10.1002/nbm. 1696. Published March 24, 2011. Accessed 2011.